Early Atherosclerosis in Familial Hypercholesterolemia Patients: Significance of Vascular Markers for Risk Stratification.

ankle–brachial index cardio-vascular index carotid intima–media thickness familial hypercholesterolemia flow-mediated dilation pulse wave velocity

Journal

Journal of cardiovascular development and disease
ISSN: 2308-3425
Titre abrégé: J Cardiovasc Dev Dis
Pays: Switzerland
ID NLM: 101651414

Informations de publication

Date de publication:
13 Mar 2024
Historique:
received: 21 02 2024
revised: 09 03 2024
accepted: 12 03 2024
medline: 27 3 2024
pubmed: 27 3 2024
entrez: 27 3 2024
Statut: epublish

Résumé

Familial hypercholesterolemia (FH) is a genetic disorder that manifests as impaired low-density lipoprotein cholesterol (LDL-C) metabolism, resulting in lifelong exposure to high cholesterol levels and increased risk of cardiovascular disease (CVD). There is heterogeneity in cardiovascular risk for FH patients, so risk stratification is of utmost importance. The aim of this study was to evaluate the impact of increases in LDL-C and the impact of other CVD risk factors on vascular markers in the FH patient population. A total of 428 patients were included in this study and divided into two groups according to age: ≤40 years in the first group and ≥41 years in the second group. Vascular markers of atherosclerosis included the common carotid artery (CCA) intima-media thickness (IMT), pulse wave velocity (PWV), flow-mediated dilation (FMD), ankle-brachial index (ABI), and cardio-vascular index (CAVI). The influence of traditional CVD risk factors on atherosclerotic changes in vascular markers was analyzed. A statistically significant difference in IMT was detected between the same sex and different age groups ( Although vascular markers of atherosclerosis may provide a unique and valuable way to evaluate cardiovascular risk, the results of this study show that only increased IM thickness could be beneficial for risk stratification in young FH patients, whereas other vascular markers of atherosclerosis would be excessive, as they do not provide merit in risk evaluation in this population.

Sections du résumé

BACKGROUND BACKGROUND
Familial hypercholesterolemia (FH) is a genetic disorder that manifests as impaired low-density lipoprotein cholesterol (LDL-C) metabolism, resulting in lifelong exposure to high cholesterol levels and increased risk of cardiovascular disease (CVD). There is heterogeneity in cardiovascular risk for FH patients, so risk stratification is of utmost importance. The aim of this study was to evaluate the impact of increases in LDL-C and the impact of other CVD risk factors on vascular markers in the FH patient population.
METHODS METHODS
A total of 428 patients were included in this study and divided into two groups according to age: ≤40 years in the first group and ≥41 years in the second group. Vascular markers of atherosclerosis included the common carotid artery (CCA) intima-media thickness (IMT), pulse wave velocity (PWV), flow-mediated dilation (FMD), ankle-brachial index (ABI), and cardio-vascular index (CAVI). The influence of traditional CVD risk factors on atherosclerotic changes in vascular markers was analyzed.
RESULTS RESULTS
A statistically significant difference in IMT was detected between the same sex and different age groups (
CONCLUSIONS CONCLUSIONS
Although vascular markers of atherosclerosis may provide a unique and valuable way to evaluate cardiovascular risk, the results of this study show that only increased IM thickness could be beneficial for risk stratification in young FH patients, whereas other vascular markers of atherosclerosis would be excessive, as they do not provide merit in risk evaluation in this population.

Identifiants

pubmed: 38535114
pii: jcdd11030091
doi: 10.3390/jcdd11030091
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Urte Aliosaitiene (U)

Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania.
Clinic of Cardiac and Vascular Diseases, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania.

Zaneta Petrulioniene (Z)

Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania.
Clinic of Cardiac and Vascular Diseases, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania.

Egidija Rinkuniene (E)

Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania.
Clinic of Cardiac and Vascular Diseases, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania.

Antanas Mainelis (A)

Faculty of Mathematics and Informatics, Vilnius University, LT-01513 Vilnius, Lithuania.

Jurate Barysiene (J)

Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania.
Clinic of Cardiac and Vascular Diseases, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania.

Urte Smailyte (U)

Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania.

Vaida Sileikiene (V)

Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania.
Clinic of Cardiac and Vascular Diseases, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania.

Aleksandras Laucevicius (A)

Faculty of Medicine, Vilnius University, LT-01513 Vilnius, Lithuania.
Clinic of Cardiac and Vascular Diseases, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania.

Classifications MeSH